-
Published 10/8/2025
Malatesta S, Carney T, Niemand Wolhuter N, Overbeck V, Theron D, Weber SE, Meade CS, Thomson S, Bouton TC, Farhat M, Myers B, Wood R, Ratangee F, Horsburgh CR, White LF, Warren RM, Jacobson KR. Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa. J Infect Dis. 2025 Oct 08. PMID: 41060285.
-
Published 8/29/2025
Niemand N, Rooney JA, Malatesta S, Rawoot N, Bouton TC, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiol Spectr. 2025 Aug 29; e0096925. PMID: 40879468.
-
Published 8/29/2025
Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Rifampin versus isoniazid completion rates for TB infection. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):425-427. PMID: 40883884.
-
Published 4/20/2025
Thomson SJ, Mistry R, Bayly H, Overbeck V, Sagar M, Schechter-Perkins EM, White LF, Jacobson KR, Bouton TC. Barriers to recruitment of an observational SARS-CoV-2 emergency department cohort at Boston Medical Center. BMC Emerg Med. 2025 Apr 20; 25(1):68. PMID: 40254607.
-
Published 3/27/2025
Niemand N, Rooney JA, Malatesta S, Rawoot N, Bouton TC, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. medRxiv. 2025 Mar 27. PMID: 40196277.